Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Boige V, Bérille J, Conroy T. Gourgou-Bourgade S, et al. J Clin Oncol. 2013 Jan 1;31(1):23-9. doi: 10.1200/JCO.2012.44.4869. Epub 2012 Dec 3. J Clin Oncol. 2013. PMID: 23213101 Clinical Trial.
Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.
Anota A, Bascoul-Mollevi C, Conroy T, Guillemin F, Velten M, Jolly D, Mercier M, Causeret S, Cuisenier J, Graesslin O, Hamidou Z, Bonnetain F. Anota A, et al. Health Qual Life Outcomes. 2014 Mar 8;12:32. doi: 10.1186/1477-7525-12-32. Health Qual Life Outcomes. 2014. PMID: 24606836 Free PMC article. Clinical Trial.
[Impacts of routine patient-reported-outcomes monitoring in oncology].
Fiteni F, Favier M, Bascoul-Mollevi C, Gourgou S, Cousin C, Houédé N. Fiteni F, et al. Among authors: bascoul mollevi c. Bull Cancer. 2018 Sep;105(9):847-848. doi: 10.1016/j.bulcan.2018.06.010. Epub 2018 Jul 20. Bull Cancer. 2018. PMID: 30032955 French. No abstract available.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER PRODIGE 23): Health-related quality of life longitudinal analysis.
Bascoul-Mollevi C, Gourgou S, Borg C, Etienne PL, Rio E, Rullier E, Juzyna B, Castan F, Conroy T. Bascoul-Mollevi C, et al. Eur J Cancer. 2023 Jun;186:151-165. doi: 10.1016/j.ejca.2023.03.021. Epub 2023 Mar 24. Eur J Cancer. 2023. PMID: 37068407 Clinical Trial.
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan.
Del Rio M, Molina F, Bascoul-Mollevi C, Copois V, Bibeau F, Chalbos P, Bareil C, Kramar A, Salvetat N, Fraslon C, Conseiller E, Granci V, Leblanc B, Pau B, Martineau P, Ychou M. Del Rio M, et al. J Clin Oncol. 2007 Mar 1;25(7):773-80. doi: 10.1200/JCO.2006.07.4187. J Clin Oncol. 2007. PMID: 17327601 Free PMC article.
50 results